2017 AATS共识指南:脓胸的管理

2017-02-04 美国胸外科协会 J Thorac Cardiovasc Surg. 2017 Feb 4.

2017年2月,美国胸外科协会(AATS)发布了脓胸的管理指南,该指南建议主要内容包括:实验室以及胸水分析,急性脓胸抗生素治疗,急性脓胸胸腔引流术等。

中文标题:

2017 AATS共识指南:脓胸的管理

英文标题:

The American Association for Thoracic Surgery consensus guidelines for the management of empyema.

发布机构:

美国胸外科协会

发布日期:

2017-02-04

简要介绍:

2017年2月,美国胸外科协会(AATS)发布了脓胸的管理指南,该指南建议主要内容包括:实验室以及胸水分析,急性脓胸抗生素治疗,急性脓胸胸腔引流术等。 

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 AATS共识指南:脓胸的管理)] GetToolGuiderByIdResponse(projectId=1, id=868611c001391677, title=2017 AATS共识指南:脓胸的管理, enTitle=The American Association for Thoracic Surgery consensus guidelines for the management of empyema., guiderFrom=J Thorac Cardiovasc Surg. 2017 Feb 4., authorId=null, author=, summary=2017年2月,美国胸外科协会(AATS)发布了脓胸的管理指南,该指南建议主要内容包括:实验室以及胸水分析,急性脓胸抗生素治疗,急性脓胸胸腔引流术等。, cover=, journalId=null, articlesId=null, associationId=58, associationName=美国胸外科协会, associationIntro=AATS由胸外科领域的先驱者成立于1917年,目前是一个拥有超过1200名会员的国际性组织,会员由来自35个不同国家的顶级心胸外科医生组成。申请入会的外科医生必须在心胸外科领域取得了一定荣誉或对心胸疾病现有知识作出了一定贡献。协会通过年会、研究基金和奖励、教育座谈会和课程和旗下官方期刊the Journal of Thoracic and Cardiovascular Surgery (JTCVS)来促进对本学科的科学、教育和研究的发展。, copyright=0, guiderPublishedTime=Sat Feb 04 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=2017年2月,美国胸外科协会(AATS)发布了脓胸的管理指南,该指南建议主要内容包括:实验室以及胸水分析,急性脓胸抗生素治疗,急性脓胸胸腔引流术等。 <div>拓展指南:<strong>与<font color=red>脓胸</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=868611c001391677" title="2017 AATS共识指南:脓胸的管理" target=_blank>2017 AATS共识指南:脓胸的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=a70391c001218335" title="2015 EACTS专家共识声明:脓胸的手术治疗" target=_blank>2015 EACTS专家共识声明:脓胸的手术治疗</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%84%93%E8%83%B8" target=_blank>有关脓胸更多指南</a></ul></div>, tagList=[TagDto(tagId=23037, tagName=脓胸)], categoryList=[CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=18386, appHits=579, showAppHits=0, pcHits=5609, showPcHits=14609, likes=123, shares=10, comments=4, approvalStatus=1, publishedTime=Mon Mar 13 13:00:54 CST 2017, publishedTimeString=2017-02-04, pcVisible=1, appVisible=1, editorId=5295979, editor=rita, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=rita, createdTime=Mon Mar 13 13:00:54 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:24:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 AATS共识指南:脓胸的管理)])
2017 AATS共识指南:脓胸的管理
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1057379, encodeId=2b71105e379e6, content=脓胸的治疗很麻烦,对患者的影响比较大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=830f2464103, createdName=Bureaukey, createdTime=Mon Oct 04 08:27:33 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013222, encodeId=c5991013222b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Tue Aug 31 15:58:09 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322858, encodeId=c365322858ea, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/2BFFC04E465B96CB96FE4C8654DF1CA9/100, createdBy=cc8e2377433, createdName=在磨碎, createdTime=Sat Jun 09 21:56:57 CST 2018, time=2018-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183421, encodeId=52e5183421b7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzXprUCFDMuY1SXH96r8MdtExF6fhSNLulicdUBcsodicYROXqf5icqDWFAOicfEqYtDcjL6HvrQrvmO1/0, createdBy=db841700299, createdName=克勤, createdTime=Wed Mar 29 07:42:53 CST 2017, time=2017-03-29, status=1, ipAttribution=)]
    2021-10-04 Bureaukey

    脓胸的治疗很麻烦,对患者的影响比较大

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1057379, encodeId=2b71105e379e6, content=脓胸的治疗很麻烦,对患者的影响比较大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=830f2464103, createdName=Bureaukey, createdTime=Mon Oct 04 08:27:33 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013222, encodeId=c5991013222b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Tue Aug 31 15:58:09 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322858, encodeId=c365322858ea, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/2BFFC04E465B96CB96FE4C8654DF1CA9/100, createdBy=cc8e2377433, createdName=在磨碎, createdTime=Sat Jun 09 21:56:57 CST 2018, time=2018-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183421, encodeId=52e5183421b7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzXprUCFDMuY1SXH96r8MdtExF6fhSNLulicdUBcsodicYROXqf5icqDWFAOicfEqYtDcjL6HvrQrvmO1/0, createdBy=db841700299, createdName=克勤, createdTime=Wed Mar 29 07:42:53 CST 2017, time=2017-03-29, status=1, ipAttribution=)]
    2021-08-31 amma229

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1057379, encodeId=2b71105e379e6, content=脓胸的治疗很麻烦,对患者的影响比较大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=830f2464103, createdName=Bureaukey, createdTime=Mon Oct 04 08:27:33 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013222, encodeId=c5991013222b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Tue Aug 31 15:58:09 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322858, encodeId=c365322858ea, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/2BFFC04E465B96CB96FE4C8654DF1CA9/100, createdBy=cc8e2377433, createdName=在磨碎, createdTime=Sat Jun 09 21:56:57 CST 2018, time=2018-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183421, encodeId=52e5183421b7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzXprUCFDMuY1SXH96r8MdtExF6fhSNLulicdUBcsodicYROXqf5icqDWFAOicfEqYtDcjL6HvrQrvmO1/0, createdBy=db841700299, createdName=克勤, createdTime=Wed Mar 29 07:42:53 CST 2017, time=2017-03-29, status=1, ipAttribution=)]
    2018-06-09 在磨碎

    有中文版吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1057379, encodeId=2b71105e379e6, content=脓胸的治疗很麻烦,对患者的影响比较大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=830f2464103, createdName=Bureaukey, createdTime=Mon Oct 04 08:27:33 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013222, encodeId=c5991013222b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Tue Aug 31 15:58:09 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=322858, encodeId=c365322858ea, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/2BFFC04E465B96CB96FE4C8654DF1CA9/100, createdBy=cc8e2377433, createdName=在磨碎, createdTime=Sat Jun 09 21:56:57 CST 2018, time=2018-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183421, encodeId=52e5183421b7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzXprUCFDMuY1SXH96r8MdtExF6fhSNLulicdUBcsodicYROXqf5icqDWFAOicfEqYtDcjL6HvrQrvmO1/0, createdBy=db841700299, createdName=克勤, createdTime=Wed Mar 29 07:42:53 CST 2017, time=2017-03-29, status=1, ipAttribution=)]
    2017-03-29 克勤

    不错

    0